Software Healthcare Sector

Oceania Healthcare

Market Cap: NZ$583.0m

Owns and operates retirement villages and care centres in New Zealand.

Abeona Therapeutics

Market Cap: US$348.3m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

SAB Biotherapeutics

Market Cap: US$343.9m

A clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States.

Immuneering

Market Cap: US$342.9m

A late-stage oncology company, develops medicines for broad populations of cancer patients in the United States.

Prenetics Global

Market Cap: US$340.9m

Operates as a consumer health sciences company in the United States and Hong Kong.

SNDL

Market Cap: US$340.7m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally.

Viemed Healthcare

Market Cap: US$337.1m

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.

Opus Genetics

Market Cap: US$336.9m

A clinical-stage biopharmaceutical company, develops gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs) and other types of therapies for additional ophthalmic disorders.

ProQR Therapeutics

Market Cap: US$330.2m

A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

YD Bio

Market Cap: US$329.8m

A biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.

Electromed

Market Cap: US$326.6m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.

TriSalus Life Sciences

Market Cap: US$324.5m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.

Orchestra BioMed Holdings

Market Cap: US$322.2m

Operates as a biomedical company in the United States.

ACC Aviation Holdings

Market Cap: US$319.3m

Engages in the development of cannabis powder products.

Vanda Pharmaceuticals

Market Cap: US$319.2m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Elite Pharmaceuticals

Market Cap: US$317.8m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Sanara MedTech

Market Cap: US$316.5m

A medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States.

Integrated Diagnostics Holdings

Market Cap: US$313.9m

A consumer healthcare company, provides medical diagnostics services to patients.

AVITA Medical

Market Cap: US$311.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

InflaRx

Market Cap: US$309.5m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Neumora Therapeutics

Market Cap: US$306.3m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

Myriad Genetics

Market Cap: US$306.1m

A molecular diagnostics and precision medicine company, develops molecular tests.

Bicycle Therapeutics

Market Cap: US$305.9m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

Cartesian Therapeutics

Market Cap: US$303.8m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

CapsoVision

Market Cap: US$301.3m

A medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.

Anavex Life Sciences

Market Cap: US$300.3m

Operates as a biopharmaceutical company.

Anbio Biotechnology

Market Cap: US$298.9m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally.

Amarin

Market Cap: US$297.6m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

Embecta

Market Cap: US$296.3m

A medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.

Racura Oncology

Market Cap: AU$410.7m

Operates as a Phase 3 clinical biopharmaceutical company for cancer care.

Invivyd

Market Cap: US$293.7m

Engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States.

Fulcrum Therapeutics

Market Cap: US$292.2m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

Anika Therapeutics

Market Cap: US$291.5m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.

Northwest Biotherapeutics

Market Cap: US$289.3m

A biotechnology company, engages in the development of personalized immune therapies for cancer.

CytoDyn

Market Cap: US$288.4m

A clinical-stage biotechnology company, develops treatments for multiple therapeutic indications.

AC Immune

Market Cap: US$288.3m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.